Patent details

Basic Information

Publication number:

EP1854800

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP070114467

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Antitumoral derivatives of Ecteinascidin ET-743

French Title of Invention:

Dérivés d'ecteinascidin (ET-743) en tant qu'agents anti-tumoraux

German Title of Invention:

Tumorhemmende Derivate von Ecteinascidin ET-743

SPC Number:

Dates

Filing date:

17/07/2002

Grant date:

27/06/2012

EP Publication Date:

27/06/2012

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

14/11/2007

EP B1 Publication Date:

27/06/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

17/07/2022

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/07/2002

 

 

Name:

Pharma Mar S.A.

Address:

Calle de la Calera 3 Poligono Industrial de Tres Cantos Tr, 28760 Madrid, Spain (ES)

Agent

Name:

MARKS & CLERK LLP

From:

28/08/2012

Address:

BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

1

Name:

Gallego Pilar

Address:

Spain (ES)

2

Name:

Martinez Valentin

Address:

Spain (ES)

3

Name:

Munt Simon

Address:

Spain (ES)

4

Name:

Flores Maria

Address:

Spain (ES)

5

Name:

Cuevas Carmen

Address:

Spain (ES)

6

Name:

Manzanares Ignacio

Address:

Spain (ES)

Priority

Priority Number:

0117402

Priority Date:

17/07/2001

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

C07D 515/22;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

27/07/2021

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

Computer Packages INC

Filing date	Document type	Number of pages
12/08/2022	Request For Change	1
02/09/2022	Outgoing Correspondence	56